- Home
- EVGO vs PRQR Comparison
EVGO vs PRQR Comparison
Compare EVGO & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVGO
- PRQR
- Stock Information
- Founded
- EVGO 2010
- PRQR 2012
- Country
- EVGO United States
- PRQR Netherlands
- Employees
- EVGO N/A
- PRQR N/A
- Industry
- EVGO Other Specialty Stores
- PRQR Biotechnology: Pharmaceutical Preparations
- Sector
- EVGO Consumer Discretionary
- PRQR Health Care
- Exchange
- EVGO Nasdaq
- PRQR Nasdaq
- Market Cap
- EVGO 376.5M
- PRQR 309.5M
- IPO Year
- EVGO N/A
- PRQR 2014
- Fundamental
- Price
- EVGO $3.83
- PRQR $1.55
- Analyst Decision
- EVGO Strong Buy
- PRQR Strong Buy
- Analyst Count
- EVGO 10
- PRQR 6
- Target Price
- EVGO $5.78
- PRQR $9.00
- AVG Volume (30 Days)
- EVGO 3.9M
- PRQR 678.2K
- Earning Date
- EVGO 05-06-2025
- PRQR 05-08-2025
- Dividend Yield
- EVGO N/A
- PRQR N/A
- EPS Growth
- EVGO N/A
- PRQR N/A
- EPS
- EVGO N/A
- PRQR N/A
- Revenue
- EVGO $276,954,000.00
- PRQR $21,212,711.00
- Revenue This Year
- EVGO $39.82
- PRQR $6.44
- Revenue Next Year
- EVGO $32.12
- PRQR N/A
- P/E Ratio
- EVGO N/A
- PRQR N/A
- Revenue Growth
- EVGO 45.15
- PRQR 85.91
- 52 Week Low
- EVGO $1.78
- PRQR $1.07
- 52 Week High
- EVGO $9.07
- PRQR $4.62
- Technical
- Relative Strength Index (RSI)
- EVGO 79.08
- PRQR 50.51
- Support Level
- EVGO $2.66
- PRQR $1.50
- Resistance Level
- EVGO $4.17
- PRQR $2.02
- Average True Range (ATR)
- EVGO 0.23
- PRQR 0.17
- MACD
- EVGO 0.13
- PRQR 0.03
- Stochastic Oscillator
- EVGO 81.13
- PRQR 48.04
About EVGO EVgo Inc.
EVgo owns and operates a public direct current fast-charging network in the US. Its network of charging stations provides electric vehicle charging infrastructure to consumers and businesses. The network is capable of charging all EV models and meets all charging standards currently available in the US. EVgo partners with national and regional chains of grocery stores, automotive original equipment manufacturers, hotels, shopping centers, gas stations, parking lot operators, local governments, and independent property owners to locate and deploy its EV charging infrastructure.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceuticals company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.